home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

34.22 -0.11 (-0.32%)

Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

32 33 Next >

Disney, Occidental Petroleum And 3 Stocks To Watch Heading Into Wednesday ↗

May 10, 2023

With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Investor Sentiment Improves Slightly Ahead Of Key Inflation Reports ↗

May 10, 2023

The CNN Money Fear and Greed index showed slight improvement in overall sentiment among U.S. investors on Tuesday.

Via Benzinga

Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Several ESG Targets Ahead of Schedule

May 09, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Busy Week Ahead As Volatility Gauges Flash Red ↗

May 08, 2023

With CPI data being released on Wednesday and the Biden administration starting talks with Congress on Tuesday, it looks like this could be a big week for volatility.

Via Talk Markets

FDA Approves Teva/MedinCell's Antipsychotic Injection For Adult Schizophrenia Patients ↗

May 01, 2023

Via Benzinga

U.S. Mental Health Access Program Expands Medicine Donation to Seven New States

May 03, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults

April 28, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva to Launch New Growth Strategy at Investor Day

April 27, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 19, 2023

Via Benzinga

Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom ↗

April 17, 2023

Merck is branching into immune-mediated diseases with this takeover.

Via Investor's Business Daily

1 "Safe" Stock to Avoid and 1 to Consider Buying in April ↗

April 15, 2023

There's more to the concept of safety than having a business model that looks safe.

Via The Motley Fool

Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023

April 14, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 14, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 14, 2023

Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday.

Via Benzinga

Complete Response Letter Received for AVT02 Biologics License Application

April 13, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Trillions In Biotech Stock Gains Trace Back To This Financier ↗

April 13, 2023

Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.

Via Investor's Business Daily

Teva to Present New Data on Once-Daily AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets at the 2023 American Academy of Neurology Annual Meeting

April 11, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move ↗

April 10, 2023

Via Benzinga

7 A-Rated Stocks to Buy for April 2023 ↗

April 07, 2023

Now that the first quarter's in the bank, here are seven A-rated stocks to buy for April to keep your portfolio in top-notch shape.

Via InvestorPlace

The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat ↗

April 05, 2023

Millions of people are scrambling to get their ADHD medication. Here's why.

Via Investor's Business Daily

Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva ↗

March 31, 2023

Via Benzinga

Is Big Pharma Coming For Your Cannabis Business? ↗

March 27, 2023

Cannabis stocks have struggled in the market in recent years as the industry push to gain ground on the regulatory front hasn't progressed as quickly as investors had hoped. Yet beverage companies...

Via Benzinga

Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program Integration with a Large U.S. Health System

March 27, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

7 Strong Buy Stocks Under $10 to Snap Up Now ↗

March 23, 2023

Markets are missing out on these seven strong buy stocks under $10, which trade at too good a value score for savvy investors to ignore.

Via InvestorPlace

3 No-Brainer Stocks to Buy With $10 Right Now ↗

March 22, 2023

You don't need a large pile of money to begin building wealth on Wall Street.

Via The Motley Fool

Catalyst Pharma The No. 1 Biotech, Just Crushed 2023 Guidance Estimates ↗

March 15, 2023

The guidance includes Catalyst's newest, and second, product.

Via Investor's Business Daily

Teva Announces Early Tender Results of its Debt Tender Offer, Increases to Tender Caps and Election of Early Settlement

March 13, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

7 Core Stocks to Build a Solid Portfolio Around ↗

March 13, 2023

You’ll enjoy your investing journey more if you know that you can rely on your core of stocks to buy to provide a solid foundation.

Via InvestorPlace

Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S.

March 09, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome

March 09, 2023

By Julian Richard, Benzinga

Via TheNewswire.com

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com